VanEck Biotech ETF
BBH
BBH
82 hedge funds and large institutions have $75.4M invested in VanEck Biotech ETF in 2018 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 28 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
43% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 28
58% less capital invested
Capital invested by funds: $179M → $75.4M (-$104M)
Holders
82
Holding in Top 10
–
Calls
$1.82M
Puts
$241K
Top Buyers
| 1 | +$1.37M | |
| 2 | +$910K | |
| 3 | +$741K | |
| 4 |
PSF
Pacific Sun Financial
Los Angeles,
California
|
+$673K |
| 5 |
Goldman Sachs
New York
|
+$426K |
Top Sellers
| 1 | -$77.8M | |
| 2 | -$6.22M | |
| 3 | -$4.9M | |
| 4 |
TC
Trust Company
Manhattan,
Kansas
|
-$4.33M |
| 5 |
WI
WBI Investments
Red Bank,
New Jersey
|
-$2.61M |